Solventum Corp Q3 FY2026 results
$89.08+0.30%
Solventum Corp reported revenue of $1.95 billion, down 7.0% from a year earlier, net income of −$12.0 million and diluted earnings per share of −$0.07 against $7.22 for the third quarter of fiscal 2026 (the three months to 30 Sep 2026).
From its quarterly report, filed 5 Nov 2026. Compiled and checked by AapWire.
Q3 FY2026 against Q3 FY2025
Three months to 30 Sep 2026, against the three months to 30 Sep 2025. Amounts in USD.
| Measure | Q3 FY2026 | Q3 FY2025 | Change |
|---|---|---|---|
| Revenue | $1.95B | $2.10B | −7.0% |
| Gross profit | $1.06B | $1.14B | −6.4% |
| Gross margin | 54.5% | 54.2% | +0.3 pts |
| Operating income | $68.00M | $1.69B | −96.0% |
| Operating margin | 3.5% | 80.6% | −77.1 pts |
| Net income | −$12.00M | $1.27B | — |
| Diluted EPS | −$0.07 | $7.22 | — |
| Operating cash flow | $177.0M | $76.00M | +133% |
| Capital expenditure | $80.00M | $97.00M | −17.5% |
| Free cash flow | $97.00M | −$21.00M | — |
Operating KPIs for the quarter
| KPI | Q3 FY2026 | Change on a year |
|---|---|---|
| Organic growth (change on a year) | −4.2% | down 7.6 points |
| Cost of product revenue | $1.4B | down 10.2% |
| Cost of software and rentals revenue | $518.0M | up 3.2% |
| Infection Prevention and Surgical Solutions revenue | $683.0M | down 5.4% |
| Advanced Wound Care revenue | $528.0M | up 8.9% |
| MedSurg revenue | $1.2B | up 0.4% |
| Health Information Systems revenue | $356.0M | up 3.2% |
| Dental Solutions revenue | $317.0M | down 6.8% |
Earlier quarters
| Quarter | Period end | Revenue | Change on a year | Diluted EPS |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sep 2026 | $1.95B | −7.0% | −$0.07 |
| Q2 FY2026 | 30 Jun 2026 | $2.21B | +2.2% | $0.53 |
| Q1 FY2026 | 31 Mar 2026 | $2.01B | −3.0% | $0.07 |
| Q4 FY2025 | 31 Dec 2025 | $2.00B | −3.7% | $0.36 |
| Q3 FY2025 | 30 Sep 2025 | $2.10B | +0.7% | $7.22 |
| Q2 FY2025 | 30 Jun 2025 | $2.16B | +3.8% | $0.51 |
| Q1 FY2025 | 31 Mar 2025 | $2.07B | +2.7% | $0.78 |
| Q4 FY2024 | 31 Dec 2024 | $2.08B | +1.9% | $0.18 |
More on Solventum Corp: financial statements · revenue · earnings per share
SOLV's results, as they are filed.
Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.
